External Source

Larotrectinib For Ntrk Fusions: Patient Selection

2019 5:08
Synopsis
David S. Hong, MD, shares insight on the optimal patient selection for larotrectinib given its potential for benefit.

You Might Also Like

Patient Selection and Responses to Larotrectinib 6:01
Patient Selection And Responses To Larotrectinib
2019
Larotrectinib for Solid Tumors With NTRK Gene Fusions 7:14
Larotrectinib For Solid Tumors With Ntrk Gene Fusions
2019
FDA D.I.S.C.O.: FDA approval of larotrectinib for advanced malignancies with NTRK gene fusion 7:31
Fda D.i.s.c.o.: Fda Approval Of Larotrectinib For Advanced M...
2024
Treatment Options for NTRK Fusion–Positive mCRC 2:14
Treatment Options For Ntrk Fusion–positive Mcrc
2020
The impact of TRK inhibitor LOXO-101 (larotrectinib) on patients with TRK fusion cancers 0:52
The Impact Of Trk Inhibitor Loxo-101 (larotrectinib) On Pati...
2017
How are NTRK Gene Fusions Treated? 1:02
How Are Ntrk Gene Fusions Treated?
2020
Larotrectinib in NTRK Fusion-Positive Lung Cancer 6:03
Larotrectinib In Ntrk Fusion-positive Lung Cancer
2020
Larotrectinib, a TRK inhibitor for patients with solid tumors 1:15
Larotrectinib, A Trk Inhibitor For Patients With Solid Tumor...
2021
Larotrectinib treatment of advanced TRK fusion thyroid cancer 2:21
Larotrectinib Treatment Of Advanced Trk Fusion Thyroid Cance...
2020
Larotrectinib Is Well-Tolerated in Metastatic Solid Tumors 0:39
Larotrectinib Is Well-tolerated In Metastatic Solid Tumors
2020
Larotrectinib in adult and pediatric patients with TRK fusion-positive primary CNS tumors 3:18
Larotrectinib In Adult And Pediatric Patients With Trk Fusio...
2021
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.